Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 13, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 155
- +6 vs. Q4 2021
- Portfolio value
- $328.7M
- −$20.7M (−5.9%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 478,784 | $21.0M | 6.4% | −134,342−21.9% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 537,958 | $18.3M | 5.6% | +118,742+28.3% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 1,083,116 | $18.0M | 5.5% | +62,199+6.1% | Added | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 1,928,752 | $12.4M | 3.8% | +178,709+10.2% | Added | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 110,116 | $11.6M | 3.5% | +34,455+45.5% | Added | History |
| ACETAdicet Bio, Inc. | COM | 507,348 | $10.1M | 3.1% | +29,930+6.3% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 202,203 | $9.33M | 2.8% | +11,063+5.8% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 249,907 | $8.27M | 2.5% | +249,907 | New | History |
| PCVXVaxcyte, Inc. | COM | 315,991 | $7.63M | 2.3% | +20,880+7.1% | Added | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,843,232 | $7.48M | 2.3% | +152,122+5.7% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 239,441 | $7.32M | 2.2% | +60,303+33.7% | Added | History |
| BHVNBiohaven Ltd. | COM | 60,000 | $7.11M | 2.2% | +60,000 | New | History |
| SRRASierra Oncology, Inc. | COM NEW | 217,915 | $6.98M | 2.1% | −351,114−61.7% | Reduced | History |
| GOSSGossamer Bio, Inc. | COM | 775,315 | $6.73M | 2.0% | −391,618−33.6% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 25,000 | $6.52M | 2.0% | +25,000 | New | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 2,137,128 | $6.39M | 1.9% | +1,697,772+386.4% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 50,000 | $6.34M | 1.9% | +50,000 | New | History |
| Bellus Health Inc New07987C204 | COM NEW | 913,327 | $6.28M | 1.9% | +863,327+1,726.7% | Added | – |
| IMTXImmatics N.V. | SHS | 781,388 | $6.24M | 1.9% | +43,842+5.9% | Added | History |
| MCRBSeres Therapeutics, Inc. | COM | 840,624 | $5.99M | 1.8% | +44,721+5.6% | Added | History |
| SCPHscPharmaceuticals Inc. | COM | 970,098 | $5.51M | 1.7% | +68,736+7.6% | Added | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 86,865 | $5.41M | 1.6% | 00.0% | Unchanged | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 396,654 | $5.10M | 1.6% | +396,654 | New | History |
| AMGNAmgen Inc | Stock | 20,000 | $4.84M | 1.5% | +20,000 | New | History |
| PFEPfizer Inc | Stock | 80,000 | $4.14M | 1.3% | +80,000 | New | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 50,000 | $3.86M | 1.2% | +50,000 | New | History |
| CMRXChimerix Inc | COM | 841,203 | $3.85M | 1.2% | +45,793+5.8% | Added | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 208,368 | $3.54M | 1.1% | +11,960+6.1% | Added | History |
| INBXInhibrx Biosciences, Inc. | COM | 157,842 | $3.52M | 1.1% | +7,992+5.3% | Added | History |
| NTLAIntellia Therapeutics, Inc. | COM | 47,408 | $3.44M | 1.0% | +47,408 | New | History |
| RETAReata Pharmaceuticals Inc | CL A | 86,905 | $2.85M | 0.9% | +86,905 | New | History |
| AYLAOld Ayala, Inc | COM | 708,383 | $2.82M | 0.9% | +39,112+5.8% | Added | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 653,448 | $2.48M | 0.8% | +24,064+3.8% | Added | History |
| XFORX4 Pharmaceuticals, Inc | COM | 1,372,022 | $2.40M | 0.7% | −892,469−39.4% | Reduced | History |
| PRDSPardes Biosciences, Inc. | COM | 323,934 | $2.34M | 0.7% | −76,066−19.0% | Reduced | History |
| OVIDOvid Therapeutics Inc. | COM | 738,372 | $2.32M | 0.7% | +33,290+4.7% | Added | History |
| SVRASavara Inc | COM | 1,622,552 | $2.13M | 0.6% | +82,861+5.4% | Added | History |
| KYMRKymera Therapeutics, Inc. | COM | 50,000 | $2.12M | 0.6% | +50,000 | New | History |
| WVEWave Life Sciences, Inc. | SHS | 1,048,039 | $2.10M | 0.6% | +54,558+5.5% | Added | History |
| CABACabaletta Bio, Inc. | COM | 1,020,070 | $2.07M | 0.6% | +49,672+5.1% | Added | History |
| CNTBConnect Biopharma Holdings Ltd | ADS | 677,859 | $2.05M | 0.6% | +415,622+158.5% | Added | History |
| CLNNClene Inc. | COMMON STOCK | 514,283 | $2.03M | 0.6% | +24,962+5.1% | Added | History |
| LQDALiquidia Corp | COM NEW | 243,904 | $1.75M | 0.5% | −81,541−25.1% | Reduced | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 49,997 | $1.73M | 0.5% | −114,085−69.5% | Reduced | History |
| LYRALyra Therapeutics, Inc. | COM | 422,338 | $1.70M | 0.5% | +27,802+7.0% | Added | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 375,000 | $1.67M | 0.5% | +375,000 | New | History |
| FNCHFinch Therapeutics Group, Inc. | COM | 330,523 | $1.66M | 0.5% | +14,791+4.7% | Added | History |
| VKTXViking Therapeutics, Inc. | COM | 532,429 | $1.60M | 0.5% | +31,787+6.3% | Added | History |
| CLVSClovis Oncology, Inc. | COM | 772,339 | $1.56M | 0.5% | −340,330−30.6% | Reduced | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 372,217 | $1.55M | 0.5% | −172,602−31.7% | Reduced | History |
| TARAProtara Therapeutics, Inc. | COM STK | 296,426 | $1.51M | 0.5% | +17,170+6.1% | Added | History |
| RNTXRein Therapeutics, Inc. | COM | 2,902,086 | $1.49M | 0.5% | +138,503+5.0% | Added | History |
| RCORRenovacor, Inc. | COM | 343,283 | $1.46M | 0.4% | +381+0.1% | Added | History |
| MGNXMacrogenics Inc | COM | 164,119 | $1.45M | 0.4% | +8,072+5.2% | Added | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 362,537 | $1.43M | 0.4% | +17,959+5.2% | Added | History |
| MRUSMerus N.V. | COM | 53,703 | $1.42M | 0.4% | +2,796+5.5% | Added | History |
| NTBLNotable Labs, Ltd. | COM | 830,747 | $1.40M | 0.4% | +39,909+5.0% | Added | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 268,104 | $1.29M | 0.4% | +2,840+1.1% | Added | History |
| SYBXSynlogic, Inc. | COM | 519,775 | $1.25M | 0.4% | +35,957+7.4% | Added | History |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 181,199 | $1.23M | 0.4% | +8,890+5.2% | Added | History |
| TAOXTAO Synergies Inc. | COM NEW | 153,226 | $1.19M | 0.4% | +7,597+5.2% | Added | History |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 523,348 | $1.13M | 0.3% | +26,592+5.4% | Added | – |
| NUVBNuvation Bio Inc. | COM CL A | 213,310 | $1.12M | 0.3% | +13,310+6.7% | Added | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 87,071 | $1.08M | 0.3% | +4,736+5.8% | Added | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 78,550 | $1.07M | 0.3% | +3,990+5.4% | Added | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 1,320,155 | $1.07M | 0.3% | +97,088+7.9% | Added | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 316,939 | $1.05M | 0.3% | +6,829+2.2% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 8,763 | $1.03M | 0.3% | +363+4.3% | Added | History |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 304,161 | $1.02M | 0.3% | +14,611+5.0% | Added | History |
| MXCTMaxcyte, Inc. | COM | 137,958 | $964.0K | 0.3% | +7,958+6.1% | Added | History |
| VSTMVerastem, Inc. | COM | 678,023 | $956.0K | 0.3% | +40,652+6.4% | Added | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 510,126 | $837.0K | 0.3% | +27,516+5.7% | Added | History |
| ISEEIVERIC bio, Inc. | COM | 49,099 | $825.0K | 0.3% | +2,580+5.5% | Added | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 77,274 | $762.0K | 0.2% | +3,485+4.7% | Added | – |
| HEPAHepion Pharmaceuticals, Inc. | COM | 582,137 | $751.0K | 0.2% | +28,864+5.2% | Added | History |
| PBLAPanbela Therapeutics, Inc. | COM | 355,959 | $750.0K | 0.2% | +17,577+5.2% | Added | History |
| QSIQuantum-Si Inc | COM CL A | 157,363 | $736.0K | 0.2% | +12,957+9.0% | Added | History |
| NXTCNextCure, Inc. | COM | 141,058 | $686.0K | 0.2% | +7,003+5.2% | Added | History |
| IFRXInflaRx N.V. | COM | 349,468 | $639.0K | 0.2% | +18,420+5.6% | Added | History |
| PLRXPliant Therapeutics, Inc. | COM | 90,805 | $636.0K | 0.2% | +4,093+4.7% | Added | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 511,186 | $633.0K | 0.2% | +35,493+7.5% | Added | History |
| SLDBSolid Biosciences Inc. | COM | 521,155 | $625.0K | 0.2% | 00.0% | Unchanged | History |
| ATXSAstria Therapeutics, Inc. | COM | 92,223 | $619.0K | 0.2% | +4,643+5.3% | Added | History |
| IRONDisc Medicine, Inc. | COM | 443,096 | $615.0K | 0.2% | +22,046+5.2% | Added | History |
| QCLSQ/C Technologies, Inc. | COM | 131,389 | $612.0K | 0.2% | +7,389+6.0% | Added | History |
| TENXTenax Therapeutics, Inc. | COM NEW | 735,097 | $596.0K | 0.2% | +40,902+5.9% | Added | History |
| RLMDRelmada Therapeutics, Inc. | COM | 21,801 | $588.0K | 0.2% | +1,058+5.1% | Added | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 39,730 | $586.0K | 0.2% | +3,154+8.6% | Added | History |
| KRSAKorsana Biosciences, Inc. | COM | 527,462 | $585.0K | 0.2% | +24,835+4.9% | Added | History |
| HARPHarpoon Therapeutics, Inc. | COM | 117,009 | $582.0K | 0.2% | +5,717+5.1% | Added | History |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 35,149 | $572.0K | 0.2% | +584+1.7% | Added | History |
| AVTXAvalo Therapeutics, Inc. | COM | 764,271 | $554.0K | 0.2% | +45,566+6.3% | Added | History |
| DMACDiaMedica Therapeutics Inc. | COM NEW | 221,252 | $553.0K | 0.2% | +12,170+5.8% | Added | History |
| MBIOMustang Bio, Inc. | COM | 546,824 | $551.0K | 0.2% | +40,791+8.1% | Added | History |
| OKUROnKure Therapeutics, Inc. | COM | 185,597 | $546.0K | 0.2% | +10,597+6.1% | Added | History |
| VTVTvTv Therapeutics Inc. | CL A | 742,980 | $536.0K | 0.2% | +42,980+6.1% | Added | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM | 997,627 | $530.0K | 0.2% | +49,101+5.2% | Added | History |
| KODKodiak Sciences Inc. | COM | 68,100 | $526.0K | 0.2% | +68,100 | New | History |
| OTICOtonomy, Inc. | COM | 218,538 | $525.0K | 0.2% | +10,232+4.9% | Added | History |
| ASMBAssembly Biosciences, Inc. | COM | 227,076 | $468.0K | 0.1% | +12,215+5.7% | Added | History |
Options (31)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $84.1M |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | $19.2M | $22.1M |
| NBIXNeurocrine Biosciences Inc | Stock | – | $40.3M |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $20.3M | $11.7M |
| BMRNBiomarin Pharmaceutical Inc | COM | – | $24.2M |
| AMGNAmgen Inc | Stock | – | $24.2M |
| BIIBBiogen Inc. | COM | – | $23.6M |
| RETAReata Pharmaceuticals Inc | CL A | $21.3M | $502.0K |
| GILDGilead Sciences, Inc. | Stock | $10.8M | $10.8M |
| UTHRUnited Therapeutics Corp | COM | – | $17.9M |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $16.6M |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | $4.68M | $11.6M |
| LONALeonaBio, Inc. | COM | $2.70M | $10.6M |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $8.90M |
| SAGESage Therapeutics, Inc. | COM | – | $8.28M |
| RCUSArcus Biosciences, Inc. | COM | – | $4.73M |
| KZRKezar Life Sciences, Inc. | COM | – | $4.67M |
| PMVPPMV Pharmaceuticals, Inc. | COM | $2.08M | $2.08M |
| BPMCBlueprint Medicines Corp | COM | – | $4.09M |
| PTGXProtagonist Therapeutics, Inc | COM | – | $3.81M |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | – | $3.21M |
| ZLABZai Lab Ltd | ADR | – | $2.34M |
| GOSSGossamer Bio, Inc. | COM | $129.0K | $1.84M |
| INBXInhibrx Biosciences, Inc. | COM | – | $1.91M |
| AKBAAkebia Therapeutics, Inc. | COM | $860.0K | $575.0K |
| ACETAdicet Bio, Inc. | COM | – | $1.24M |
| CABACabaletta Bio, Inc. | COM | – | $912.0K |
| KODKodiak Sciences Inc. | COM | $565.0K | $199.0K |
| TCDATricida, Inc. | COM | $764.0K | – |
| NKTRNektar Therapeutics | COM | – | $722.0K |
| IMUXImmunic, Inc. | COM | $696.0K | – |
Sold out since Q4 2021 (10)
Positions held at the end of Q4 2021 that are gone from this filing.
| Security | Class | Shares in Q4 2021 | Value in Q4 2021 | % of portfolio in Q4 2021 | History |
|---|---|---|---|---|---|
| iShares Tr464287556 | ISHARES BIOTECH | 24,022 | $3.67M | 1.0% | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 172,521 | $3.29M | 0.9% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 23,700 | $2.01M | 0.6% | History |
| FOLDAmicus Therapeutics, Inc. | COM | 164,174 | $1.90M | 0.5% | History |
| ODTOdonate Therapeutics, Inc. | COM | 1,340,631 | $1.81M | 0.5% | History |
| RFLRafael Holdings, Inc. | COM CL B | 72,515 | $370.0K | 0.1% | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 2,161 | $200.0K | 0.1% | History |
| BBIOBridgeBio Pharma, Inc. | COM | 1,500 | $25.0K | <0.1% | History |
| BXRXBaudax Bio, Inc. | COM | 95,059 | $21.0K | <0.1% | History |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 941 | $9.00K | <0.1% | – |